Overview

Lung cancer causes more deaths than the next 3 deadliest cancers combined.2

With our advanced CT technologies and expertise, we can help you lead your community in the fight against lung cancer.

Taking a stand against the number one cancer killer in the world is no small task, but the National Lung Screening Trial (NLST) showed a compelling 20% reduction in lung cancer mortality using low-dose CT screening2 in high risk patients, prompting the approval for screening reimbursement by the U.S. Preventive Services Task Force (USPSTF) and the Centers for Medicare and Medicaid Services (CMS). 3,4

We’re proud to be the first CT manufacturer with an indication for low-dose CT lung cancer screening.5,6 Using qualified GE CT scanners and our new low-dose CT lung cancer screening protocols, you can increase early detection in high-risk patients and help prevent a substantial number of lung cancer related deaths.7

All new GE 64-slice and greater CT scanners and virtually all of our 16-slice CT scanners include the screening option and the option is also available to thousands of qualified GE CT scanners currently in use, increasing access for both patient and physician lung cancer screening needs.

GE low-dose CT lung cancer screening protocols are tailored to the CT system, patient size and the most current recommendations from a wide range of professional medical and governmental organizations.

Implementing a low-dose CT lung cancer screening program gives you the ability to change lives in your patient community but also has the potential to dramatically increase the demands of your radiology department and beyond.  Are you ready? Contact us to find out how we can help.
 

Qualified Systems

Now, qualified GE CT systems with the lung cancer screening option can be confidently used for low-dose CT lung cancer screening in high-risk patients.

The option includes protocols that deliver low dose, short scan times and sharp images for the detection of small lung nodules.

The GE CT system requirements for lung cancer screening are designed to help ensure that the CT scan can be performed in a single breath by the patient and at a low radiation dose. Based on these goals, and including recommendations from a wide range of professional medical and governmental organizations, all GE 64-slice and greater CT scanners and virtually all GE 16-slice CT scanners are qualified for the lung cancer screening option. 

The following systems are qualified for the new low-dose CT lung cancer screening option:

RevolutionTM Family

  • Revolution CT
  • Revolution GSI
  • Revolution HD
  • Revolution EVO

OptimaTM Family

  • Optima CT660
  • Optima CT580 RT with 16-slice CT
  • Optima CT580 W
  • Optima CT540

DiscoveryTM Family

  • Discovery CT750 HD
  • Discovery CT590 RT

SPECT/CT Family

  • Discovery CT670 with 16-slice CT
  • Discovery CT670 Pro

PET/CT Family

  • Discovery IQ
  • Discovery PET/CT 610
  • Discovery PET/CT 710

LightSpeedTM Family

  • LightSpeed VCT
  • LightSpeed VCT Select
  • LightSpeed Pro16
  • LightSpeed RT16
  • LightSpeed Xtra

BrightSpeedTM Family

  • BrightSpeed Elite

I would like a GE Sales Representative to contact me about this option.

Resources

Want more information on low-dose CT lung cancer screening? 

Here are some helpful resources.

General background information

CMS Decision Memo for Lung Cancer Screening: Outlines eligibility requirements as defined by CMS for receiving Medicare coverage for lung cancer screening.  Note the CMS beneficiary eligibility requirements are slightly different than the USPSTF requirements. 

USPSTF Lung Cancer Screening Recommendation Statement: Outlines the USPSTF recommendation for lung cancer screening.  It includes a recommendation summary, rationale, clinical consideration and outlines the at-risk population.

USPSTF Clinical Summary: One page summary of the USPSTF lung cancer screening recommendation.

 

Lung cancer screening resources

ACR Lung Cancer Screening Resources: A comprehensive listing of resources relevant to starting a lung cancer screening program including registry information, how to become a designated lung cancer screening center, coverage and patient information.

American Lung Association Lung Cancer Screening Guidelines: An update from the American Lung Association Lung Cancer Screening Committee that provides guidance on lung cancer screening to patients and physicians.

 

Patient resources

NCCN Guidelines for Patients: The National Comprehensive Cancer Network (NCCN) Guidelines for Patients created in collaboration with the Lung Cancer Alliance.

Should I Screen: Online resource for patients created by the University of Michigan.

 

Additional resources

Lung Cancer Alliance: Risk and screening information from the LCA.

NOTE: The information on this page is provided for informational purposes only. Consult your physician if you have questions about low-dose CT lung cancer screening.


Related

Clarity Magazine

Clarity

The Molecular Imaging & Computed Tomography Magazine

Clarity is returning after a two-year hiatus! We intend to publish Clarity semi-annually to offer you the latest information on both Molecular Imaging and CT innovations here at GE Healthcare designed to help you achieve the best possible outcomes.

Click here to sign up for your complimentary subscription so you don’t miss a single edition of Clarity!



References

Not yet CE marked. For countries that require CE marking, this product cannot be placed on the market or put into service until made to comply with the Medical Device Directive requirements for CE marking. Not available for sale in all regions.

  1. The National Lung Screening Trial Research Team. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. N Engl J Med 2011;365:395-409. http://www.nejm.org/doi/full/10.1056/NEJMoa1102873
  2. National Cancer Institute. Surveillance, Epidemiology and End Results Program (SEER). SEER Stat Fact Sheets: Lung and Bronchus Cancer. http://seer.cancer.gov/statfacts/html/lungb.html
  3. The USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults aged 55 to 80 years who have a 30 pack-year smoking history and currently smoke or have quit within the past 15 years. 
  4. CMS has determined that those beneficiaries who are 55-77, asymptomatic, have a tobacco smoking history of at least 30 pack-years, are a current smoker or one who has quit smoking within the last 15 years; and receives a written order for LDCT lung cancer screening may receive an annual screening for lung cancer with low-dose computed tomography (LDCT), as an additional preventive service benefit under the Medicare program. CMS: Decision Memo for Screening for Lung Cancer with Low- Dose Computed Tomography (LDCT) (CAG-00439N).
  5. The FDA has cleared the following qualified GE Healthcare CT scanners to receive the new low-dose CT Lung Cancer Screening Option: RevolutionTM CT, Revolution GSI, Revolution HD, Revolution EVO, Revolution DiscoveryTM CT, Discovery CT750 HD, Discovery CT590 RT, OptimaTM CT660, Optima CT540, Optima CT580 RT with 16-slice CT, Optima CT580 W, LightSpeedTM Xtra, LightSpeed RT16, LightSpeed Pro32, LightSpeed VCT Select, LightSpeed VCT XT, LightSpeed VCT XTe, LightSpeed VCT, LightSpeed Pro16, LightSpeed 16 and BrightSpeedTM Elite. The following PET/CT and SPECT/CT systems that use the qualified CT systems are also eligible to receive the lung cancer screening option: Discovery IQ, Discovery PET/CT 610, Discovery PET/CT 710, Discovery CT670 with 16-slice CT and Discovery CT670 Pro.
  6. The Low-Dose CT (LDCT) Lung Cancer Screening Option (LCS) for qualified GE Systems is indicated for using low-dose CT for lung cancer screening. The screening must be performed within the established inclusion criteria of programs/protocols that have been approved and published by either a governmental body or professional medical society. 
  7. Moyer V. Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2014;160:330-338. http://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/lung-cancer-screening.